As a boardcertified plastic surgeon with a strong interest in holistic wellness, Dr
The results of SELECT, which examined the effect of subcutaneous semaglutide injection for the prevention of cardiovascular events in 17,604 patients with obesity (body mass index [BMI] 27 kg/m 2 ) and established cardiovascular disease but without diabetes, were presented in 2023 [25]
Personalized Treatment Planning If treatment is a good fit, we build a plan around your starting pointbecause weight loss isnt one plan for everyone. Well outline what to expect in the first few weeks, what to monitor, and how well measure progress beyond the scale
Is there a Mounjaro tablet
Within that population, 67.8% were female, the average patient age was 49.6 and 26.6% had type 2 diabetes